400 results
424B3
MBOT
Microbot Medical Inc
16 May 24
Prospectus supplement
4:30pm
Months Ended March 31,
Unaudited
Research and development, net
General and administrative
Operating loss
Financing income, net
Net loss
Basic … grants from the Israeli Innovation Authority (“IIA”) for participation in research and development since 2013 through March 31, 2024 totaling
424B3
MBOT
Microbot Medical Inc
4 Apr 24
Prospectus supplement
4:22pm
operating history outside of being a research and development-stage company, which may make it difficult to evaluate the prospects for the Company’s … in doing so, Microbot’s business will be materially harmed.
The results of Microbot’s research and development efforts are uncertain and there can
424B3
ilwny0w ng
30 Jan 24
Prospectus supplement
4:30pm
8-K
w8s5zaio kxl6d
30 Nov 23
Other Events
7:18pm
8-K
EX-10.1
vxhwd pcz3qbmwwd
21 Nov 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-99.1
z1pxvq6
21 Nov 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-99.1
qn6emw4b35durp5
15 Aug 23
Microbot Medical Boosts Manufacturing and Commercialization Capabilities for its Robotic Surgical System
8:30am
424B3
o6bqd69da f7vz
18 Jul 23
Prospectus supplement
2:48pm